Avanafil TMS
Compound with spectra: 1 MS (GC)
| SpectraBase Compound ID | FClVAkcaPTf |
|---|---|
| InChI | InChI=1S/C26H34ClN7O3Si/c1-36-22-9-8-18(13-21(22)27)14-30-24-20(25(35)31-16-23-28-10-6-11-29-23)15-32-26(33-24)34-12-5-7-19(34)17-37-38(2,3)4/h6,8-11,13,15,19H,5,7,12,14,16-17H2,1-4H3,(H,31,35)(H,30,32,33) |
| InChIKey | VXSBBXQUEFHBFG-UHFFFAOYSA-N |
| Mol Weight | 556.1 g/mol |
| Molecular Formula | C26H34ClN7O3Si |
| Exact Mass | 555.218092 g/mol |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
- Spedra TMS
- Stendra TMS
- 4-((3-chloro-4-methoxybenzyl)amino)-N-(pyrimidin-2-ylmethyl)-2-(2-(((trimethylsilyl)oxy)methyl)\rpyrrolidin-1-yl)pyrimidine-5-carboxamide
7-Amino-5-methyl-3-phenylpyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione
5(6H)-quinazolinone, 7,8-dihydro-4-[(4-methylphenyl)amino]-2-[4-(2-pyrimidinyl)-1-piperazinyl]-
5(6H)-quinazolinone, 7,8-dihydro-2-[4-(4-methoxyphenyl)-1-piperazinyl]-7,7-dimethyl-4-(methylamino)-
7-(difluoromethyl)-N-(3,4-dimethoxybenzyl)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide
1-piperazinecarboxylic acid, 4-[5,6,7,8-tetrahydro-5-oxo-4-(phenylamino)-2-quinazolinyl]-, ethyl ester
5(6H)-quinazolinone, 7,8-dihydro-4-[(4-methoxyphenyl)amino]-2-(4-methyl-1-piperazinyl)-
5(6H)-quinazolinone, 7,8-dihydro-2-[4-(2-hydroxyethyl)-1-piperazinyl]-4-[(4-methoxyphenyl)amino]-
No Name
5(6H)-quinazolinone, 7,8-dihydro-2-[4-(2-hydroxyethyl)-1-piperazinyl]-4-[(4-methylphenyl)amino]-
5(6H)-quinazolinone, 7,8-dihydro-7-(3-methylphenyl)-2-[4-(2-pyridinyl)-1-piperazinyl]-
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.